| 产品名称: | Campylobacter fetus subsp. testudinum |
|---|---|
| 商品货号: | TS257430 |
| <strong>Name </strong>: | Campylobacter fetus subsp. testudinum Fitzgerald et al. 2014 |
| <strong>DSM No. </strong>: | 105764, Type strain dsm-105764 dsm105764 dsm 105764 Campylobacter fetus subsp. testudinum |
| Strain designation : | 03-427, Blaser 03-427 |
| Other collection no. <br />or WDCM no. : | ATCC BAA-2539, LMG 27499 |
| Isolated from : | human blood culture |
| Country : | United States of America New York |
| Date of sampling : | before 2003 |
| <strong>Nagoya Protocol Restrictions </strong>: | There are NO known Nagoya Protocol restrictions for this strain. |
| History : | |
| Genbank accession numbers : | complete genome: CP006833 |
| Cultivation conditions : | Medium 693 , microaerophilic (82,5% N2; 4% CO2; 7,5% H2; 6% O2), 37°C for reactivation distribute the complete content of the ampoule on one agar plate Incubation time: 1-2 days Complete DSMZ Media List |
| Summary and <br />additional information : | Type strain. Taxonomy/description (19886). Sequence accession no. complete genome: CP006833. (Medium 693, 37°C, microaerophilic (82,5% N2; 4% CO2; 7,5% H2; 6% O2)). For reactivation distribute the complete content of the ampoule on one agar plate. |
| For detailed information : | BacDive - The Bacterial Diversity Metadatabase |
| Literature : | 19886 |
| Risk group : | 2 (provisional classification by DSMZ) |
| Restrictions : | Act dealing with the prevention & control of infectious diseases in man (Infektionsschutzgesetz), Category A1 |
| Other cultures : | All DSMZ cultures of the species |
| 产品名称: | Campylobacter fetus subsp. testudinum |
|---|---|
| 商品货号: | TS257430 |
| <strong>Name </strong>: | Campylobacter fetus subsp. testudinum Fitzgerald et al. 2014 |
| <strong>DSM No. </strong>: | 105764, Type strain dsm-105764 dsm105764 dsm 105764 Campylobacter fetus subsp. testudinum |
| Strain designation : | 03-427, Blaser 03-427 |
| Other collection no. <br />or WDCM no. : | ATCC BAA-2539, LMG 27499 |
| Isolated from : | human blood culture |
| Country : | United States of America New York |
| Date of sampling : | before 2003 |
| <strong>Nagoya Protocol Restrictions </strong>: | There are NO known Nagoya Protocol restrictions for this strain. |
| History : | |
| Genbank accession numbers : | complete genome: CP006833 |
| Cultivation conditions : | Medium 693 , microaerophilic (82,5% N2; 4% CO2; 7,5% H2; 6% O2), 37°C for reactivation distribute the complete content of the ampoule on one agar plate Incubation time: 1-2 days Complete DSMZ Media List |
| Summary and <br />additional information : | Type strain. Taxonomy/description (19886). Sequence accession no. complete genome: CP006833. (Medium 693, 37°C, microaerophilic (82,5% N2; 4% CO2; 7,5% H2; 6% O2)). For reactivation distribute the complete content of the ampoule on one agar plate. |
| For detailed information : | BacDive - The Bacterial Diversity Metadatabase |
| Literature : | 19886 |
| Risk group : | 2 (provisional classification by DSMZ) |
| Restrictions : | Act dealing with the prevention & control of infectious diseases in man (Infektionsschutzgesetz), Category A1 |
| Other cultures : | All DSMZ cultures of the species |